Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Pfeifer

Showing results (101-110 of 178) with videos related to

Pageof 18
Sort By:
Respiratory Medicine|May 29, 2007
NT-proBNP in chronic hypercapnic respiratory failure: a marker of disease severity, treatment effect and prognosisStephan Budweiser, Andreas Luchner, Rudolf A Jörres, et al.
Current Medical Research and Opinion|March 21, 2018
Quality goal attainment and maintenance in patients with type II diabetes mellitus initiated on canagliflozin or a glucagon-like peptide-1 receptor agonist in an actual practice settingCarol H Wysham, Dominic Pilon, Mike Ingham, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|April 22, 2016
Response to StavropoulosRaymond R Townsend, Israel Machin, Jimmy Ren, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|December 15, 2015
Reductions in Mean 24-Hour Ambulatory Blood Pressure After 6-Week Treatment With Canagliflozin in Patients With Type 2 Diabetes Mellitus and HypertensionRaymond R Townsend, Israel Machin, Jimmy Ren, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|January 27, 2018
Adaptive servo-ventilation and sleep quality in treatment emergent central sleep apnea and central sleep apnea in patients with heart disease and preserved ejection fractionKatharina Heider, Michael Arzt, Christoph Lerzer, et al.
The Annals of Thoracic Surgery|December 22, 2010
Extracorporeal circulatory systems as a bridge to lung transplantation at remote transplant centersAssad Haneya, Alois Philipp, Thomas Mueller, et al.
Sleep Medicine|May 1, 2013
Prognostic impact of sleep duration and sleep efficiency on mortality in patients with chronic heart failureWibke Reinhard, Nina Plappert, Florian Zeman, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|June 29, 2023
CT findings in "Post-Covid": residua from acute pneumonia or "Post-Covid-ILD"?Stefanie Meiler, Florian Poschenrieder, Arno Mohr, et al.
Infection|October 7, 2021
Adherence to STIKO recommendations in patients with pulmonary disease in southeast GermanyArno Mohr, Annelie Plentz, Anna Sieroslawski, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|March 17, 2018
HBA1C CONTROL AND COST-EFFECTIVENESS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS INITIATED ON CANAGLIFLOZIN OR A GLUCAGON-LIKE PEPTIDE 1 RECEPTOR AGONIST IN A REAL-WORLD SETTINGCarol H Wysham, Dominic Pilon, Mike Ingham, et al.
Pageof 18

Showing results (101-110 of 178) with videos related to

Sort By:
Pageof 18
Respiratory Medicine|May 29, 2007
NT-proBNP in chronic hypercapnic respiratory failure: a marker of disease severity, treatment effect and prognosisStephan Budweiser, Andreas Luchner, Rudolf A Jörres, et al.
Current Medical Research and Opinion|March 21, 2018
Quality goal attainment and maintenance in patients with type II diabetes mellitus initiated on canagliflozin or a glucagon-like peptide-1 receptor agonist in an actual practice settingCarol H Wysham, Dominic Pilon, Mike Ingham, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|April 22, 2016
Response to StavropoulosRaymond R Townsend, Israel Machin, Jimmy Ren, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|December 15, 2015
Reductions in Mean 24-Hour Ambulatory Blood Pressure After 6-Week Treatment With Canagliflozin in Patients With Type 2 Diabetes Mellitus and HypertensionRaymond R Townsend, Israel Machin, Jimmy Ren, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|January 27, 2018
Adaptive servo-ventilation and sleep quality in treatment emergent central sleep apnea and central sleep apnea in patients with heart disease and preserved ejection fractionKatharina Heider, Michael Arzt, Christoph Lerzer, et al.
The Annals of Thoracic Surgery|December 22, 2010
Extracorporeal circulatory systems as a bridge to lung transplantation at remote transplant centersAssad Haneya, Alois Philipp, Thomas Mueller, et al.
Sleep Medicine|May 1, 2013
Prognostic impact of sleep duration and sleep efficiency on mortality in patients with chronic heart failureWibke Reinhard, Nina Plappert, Florian Zeman, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|June 29, 2023
CT findings in "Post-Covid": residua from acute pneumonia or "Post-Covid-ILD"?Stefanie Meiler, Florian Poschenrieder, Arno Mohr, et al.
Infection|October 7, 2021
Adherence to STIKO recommendations in patients with pulmonary disease in southeast GermanyArno Mohr, Annelie Plentz, Anna Sieroslawski, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|March 17, 2018
HBA1C CONTROL AND COST-EFFECTIVENESS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS INITIATED ON CANAGLIFLOZIN OR A GLUCAGON-LIKE PEPTIDE 1 RECEPTOR AGONIST IN A REAL-WORLD SETTINGCarol H Wysham, Dominic Pilon, Mike Ingham, et al.
Pageof 18